{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:24Z","timestamp":1793694624539,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109685","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:48:59Z","timestamp":1792230539000},"page":"109685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Low-dose juglone attenuates pressure overload-induced cardiac hypertrophy through Lys207-dependent FoxO1 activation and mitochondrial protection"],"prefix":"10.1016","volume":"233","author":[{"given":"Hongyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7549-6505","authenticated-orcid":false,"given":"Chengxin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9571-9791","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.phrs.2026.109685_bib1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/eurheartj\/ehad225","volume":"44","author":"Taylor","year":"2023","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.phrs.2026.109685_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31083\/j.rcm2305165","article-title":"Cardiac hypertrophy: from pathophysiological mechanisms to heart failure development","volume":"23","author":"Caturano","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"issue":"18","key":"10.1016\/j.phrs.2026.109685_bib3","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109685_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178179","article-title":"Cardiac hypertrophy at the crossroads: mechanistic insights and emerging multimodal therapeutic strategies","volume":"1006","author":"Kannan","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109685_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1696793","article-title":"Heart failure: mechanistic insights and precision therapeutic strategies","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"25","key":"10.1016\/j.phrs.2026.109685_bib6","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/j.jacc.2026.03.029","article-title":"Contemporary management of acute heart failure: from emergency presentation to long-term remission","volume":"87","author":"Bruno","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2026.109685_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","article-title":"Mitochondrial structure and function in human heart failure","volume":"135","author":"Hinton","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.109685_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.109685_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108106","article-title":"Mitochondrial semi-autonomous inheritance in cardiovascular pathology: emerging mechanisms and therapeutic opportunities","volume":"224","author":"Xie","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.109685_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104143","article-title":"Mitochondrial translational control in cardiovascular diseases: from mechanisms to therapies","volume":"92","author":"Deng","year":"2026","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.109685_bib11","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"44","key":"10.1016\/j.phrs.2026.109685_bib12","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1093\/eurheartj\/ehad710","article-title":"Post-translational modifications upon mitochondrial dysfunction in heart failure","volume":"44","author":"Sluijter","year":"2023","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2026.109685_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00395-024-01060-2","article-title":"Mitochondrial calcium in cardiac ischemia\/reperfusion injury and cardioprotection","volume":"119","author":"Bertero","year":"2024","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2026.109685_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109685_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109685_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.951597","article-title":"Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: their therapeutic potential and possible effects of salvianolic acids","volume":"9","author":"Han","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.109685_bib17","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/ehf2.13065","article-title":"The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy","volume":"7","author":"Yu","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.phrs.2026.109685_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14010070","article-title":"Unraveling the AMPK-SIRT1-FOXO pathway: the in-depth analysis and breakthrough prospects of oxidative stress-induced diseases","volume":"14","author":"Guan","year":"2025","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.phrs.2026.109685_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119938","article-title":"The multifaceted role of Sestrin 3 (SESN3) in oxidative stress, inflammation and tumorigenesis","volume":"1872","author":"Chen","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.109685_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8040091","article-title":"Juglone in oxidative stress and cell signaling","volume":"8","author":"Ahmad","year":"2019","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.phrs.2026.109685_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.113.301084","article-title":"Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1","volume":"112","author":"Toko","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.109685_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/nar\/29.3.767","article-title":"Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription","volume":"29","author":"Chao","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.109685_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202414358","article-title":"ECSIT-X4 is required for preventing pressure overload-induced cardiac hypertrophy via regulating mitochondrial STAT3","volume":"12","author":"Lu","year":"2025","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.109685_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCRESAHA.123.322654","article-title":"Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation","volume":"133","author":"Tang","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.109685_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178025","article-title":"The proline isomerase Pin1 inhibitors PiB and juglone protect rats against lipopolysaccharide-induced respiratory inflammation","volume":"1005","author":"Kouki","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109685_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/cvr\/cvy033","article-title":"Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury","volume":"114","author":"Wang","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"13","key":"10.1016\/j.phrs.2026.109685_bib27","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1074\/jbc.RA119.011571","article-title":"Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1","volume":"295","author":"Xia","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.phrs.2026.109685_bib28","first-page":"5941","article-title":"Loss of microRNA-27a induces cardiac dysfunction through activating FoxO1","volume":"23","author":"Qin","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"20","key":"10.1016\/j.phrs.2026.109685_bib29","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.2174\/0929867325666181105120911","article-title":"Development of Pin1 inhibitors and their potential as therapeutic agents","volume":"27","author":"Nakatsu","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2026.109685_bib30","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.3390\/molecules190914902","article-title":"1,4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling","volume":"19","author":"Klotz","year":"2014","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phrs.2026.109685_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"Formation and biological targets of quinones: cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.phrs.2026.109685_bib32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"17","key":"10.1016\/j.phrs.2026.109685_bib33","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1021\/bi973162p","article-title":"Selective inactivation of parvulin-like peptidyl-prolyl cis\/trans isomerases by juglone","volume":"37","author":"Hennig","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2026.109685_bib34","article-title":"The mechanisms of Pin1 as targets for cancer therapy","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"5666","key":"10.1016\/j.phrs.2026.109685_bib35","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.phrs.2026.109685_bib36","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.bbamcr.2011.03.001","article-title":"Regulation of FoxO transcription factors by acetylation and protein-protein interactions","volume":"1813","author":"Daitoku","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.phrs.2026.109685_bib37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.110.227371","article-title":"Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes","volume":"107","author":"Hariharan","year":"2010","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.phrs.2026.109685_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/CIRCRESAHA.124.325918","article-title":"FoxO1-zDHHC4-CD36 S-acylation axis drives metabolic dysfunction in diabetes","volume":"136","author":"Dennis","year":"2025","journal-title":"Circ. Res."},{"issue":"42","key":"10.1016\/j.phrs.2026.109685_bib39","doi-asserted-by":"crossref","first-page":"23286","DOI":"10.1021\/acs.jafc.4c05945","article-title":"Enhanced SIRT1 activity by galangin mitigates UVB-induced senescence in dermal fibroblasts via p53 acetylation regulation and activation","volume":"72","author":"Wen","year":"2024","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.109685_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12896-025-01054-5","article-title":"Protective effect of lycopene\/lycopene cubosomal nanoparticles against cisplatin-induced cardiotoxicity: the function of NF-\u04a1B\/HO-1 and Sirt1\/AMPK\/PGC1-alpha signaling pathways","volume":"25","author":"Alotaibi","year":"2025","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.phrs.2026.109685_bib41","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109685_bib42","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.3892\/mmr.2016.5867","article-title":"Post-translational modifications of FOXO family proteins (review)","volume":"14","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2026.109685_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.102012","article-title":"FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders","volume":"116","author":"Oli","year":"2021","journal-title":"J. Chem. Neuroanat."},{"issue":"4","key":"10.1016\/j.phrs.2026.109685_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BCJ20210777","article-title":"FoxO transcription factors in mitochondrial homeostasis","volume":"479","author":"Cheng","year":"2022","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.phrs.2026.109685_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11658-021-00302-8","article-title":"The functions and roles of sestrins in regulating human diseases","volume":"27","author":"Chen","year":"2022","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826016002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826016002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:17:57Z","timestamp":1793693877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826016002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S1043661826016002"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109685","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose juglone attenuates pressure overload-induced cardiac hypertrophy through Lys207-dependent FoxO1 activation and mitochondrial protection","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109685"}}